Everence Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,260
| Closed | -$303K | – | 864 |
|
|
2024
Q3 | $303K | Hold |
15,260
| – | – | 0.02% | 583 |
|
|
2024
Q2 | $230 | Hold |
15,260
| – | – | 0.02% | 635 |
|
|
2024
Q1 | $243 | Hold |
15,260
| – | – | 0.02% | 644 |
|
|
2023
Q4 | $257K | Hold |
15,260
| – | – | 0.02% | 605 |
|
|
2023
Q3 | $178 | Hold |
15,260
| – | – | 0.01% | 695 |
|
|
2023
Q2 | $176K | Hold |
15,260
| – | – | 0.01% | 670 |
|
|
2023
Q1 | $253 | Sell |
15,260
-1,860
| -11% | -$31 | 0.02% | 600 |
|
|
2022
Q4 | $318 | Hold |
17,120
| – | – | 0.03% | 520 |
|
|
2022
Q3 | $220K | Buy |
+17,120
| New | +$220K | 0.02% | 619 |
|